Biblio Discovery — Demo Discovery Service

414 results

Showing 1–20 · 0.90 seconds · RSS

Journal

Journal of Comparative Effectiveness Research

Scopus

ISSN 2042-6313 · Becaris Publishing Limited · 414 articles in the index

  1. Journal Article

    Advancing real-world evidence harmonization: lessons from the UK, EMA and global policy frameworks

    Alexandros Sagkriotis

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: Real-world evidence (RWE) – defined here as clinical evidence derived from the analysis of realworld data (RWD) on patient health status and healthcare delivery – has become a cornerstone of regulatory and health technology assessment (HTA) decision making. However, despite broad consensus on…

  2. Journal Article

    Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Mexico: a systematic review

    Carla Ceballos Ruiz; Angelica Navarro

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: To investigate the data sources available in Mexico for real-world research. Materials & methods: A systematic literature review on PubMed, EMBASE and VHL using a combination of controlled vocabulary and keywords for the concepts of electronic health records, epidemiologic studies and Mexico…

  3. Journal Article

    The effect of infertility support education on treatment outcomes in women with unexplained infertility

    Tuğba Tahta; Yeliz Kaya; Vehbi Yavuz Tokgöz et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: To study the effect of infertility support education on treatment outcomes in women with unexplained infertility. Materials & methods: This quasi-experimental study with a pretest–posttest comparison group was conducted on women aged 19–45 years who were admitted to EO University Health…

  4. Journal Article

    Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospective cohort study

    Danielle L Isaman; Mark Corbett; Stella E Lee et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: To compare oral corticosteroid (OCS) burden and healthcare resource utilization (HCRU) in patients with chronic rhinosinusitis with nasal polyps undergoing functional endoscopic sinus surgery (FESS; intervention) versus not undergoing FESS. Materials & methods: Retrospective cohort study using…

  5. Journal Article

    An economic analysis of Chemo Mouthpiece versus supportive care for the reduction of oral mucositis incidence in patients receiving chemotherapy

    Richard Zuniga; Aidan Dineen; Rosemarie Velasquez et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: Oral mucositis (OM) is a common, burdensome complication of chemotherapy (CT), associated with pain, weight loss and increased infection risk. OM can result in CT dose reductions or delay subsequent cycles, compromising treatment efficacy. Current guidelines recommend oral cryotherapy with…

  6. Journal Article

    Real-world clinical outcomes of patients with localized prostate cancer treated with radical prostatectomy in SEER-Medicare

    Lawrence Karsh; Shawn Du; Jinghua He et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: This study examined the clinical outcomes of patients in the US with low/intermediate-risk localized prostate cancer (LIR-LPC) and high-risk localized prostate cancer (HR-LPC) who received radical prostatectomy (RP) as initial treatment. Materials & methods: This is a retrospective analysis of…

  7. Journal Article

    Comparing the efficacy of cipaglucosidase alfa plus miglustat with alglucosidase alfa for late-onset Pompe disease: an expanded network meta-analysis utilizing patient-level and aggregate data

    Shuai Fu; Noemi Hummel; Simon Shohet et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: Treatment options for late-onset Pompe disease (LOPD) include enzyme replacement therapy (ERT) with alglucosidase alfa (alg), cipaglucosidase alfa plus miglustat (cipa + mig) and avalglucosidase alfa. However, only one randomized controlled trial (RCT) directly compared cipa + mig and alg and…

  8. Journal Article

    Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study

    Robert G Gish; Joanna P MacEwan; Yutong Liu et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Aim: Complications of primary biliary cholangitis (PBC) are proposed to confer substantial economic burden to patients and healthcare systems. This retrospective observational study evaluated the cost of PBC-related hepatic decompensation and liver transplantation using a large administrative…

  9. Journal Article

    R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24

    Paul Arora; Sreeram V Ramagopalan

    Journal of Comparative Effectiveness Research, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    In this update, we review a new bias appraisal tool, explore lessons from a trial emulation study, and describe the development of real-world evidence guidance in the Philippines.

  10. Journal Article

    Sreeram V Ramagopalan*,1 & Annie Jullien Pannelay2 1Centre for Pharmaceutical Medicine Research, King’s College London, London, SE1 9NH, UK 2Universite´ Paris Saclay, UFR Pharmacie, Orsay, France

    Sreeram V Ramagopalan; Annie Jullien Pannelay

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    In this update we cover the impacts of the US Most Favored Nation pricing policy and research evaluating drug availability and affordability in China as a result of the National Reimbursement Drug List negotiation policy.

  11. Journal Article

    Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial

    Samuel Vennin; Will Sopwith; Emiliano Calvo et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    External comparator (EC) studies can improve identification of compounds with the most promising performance in pre-pivotal single-arm trials (SAT). As SAT output lacks comparative insights, EC studies allow efficient contextualization of compound performance in early phases of drug development…

  12. Journal Article

    Reshaping the cardiovascular continuum in the management of arterial and venous cardiovascular disease: a narrative review

    Khadija Hafidh; Melina Vega de Ceniga; Leonardo De Luca et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    The prevalence of cardiovascular disease (CVaD) is expected to double in the next 25 years, fueled by increasing prevalence of diabetes mellitus, obesity and hypertension. Cardiovascular–kidney–metabolic syndrome is a clinical entity requiring a holistic approach to prevention and management…

  13. Journal Article

    The importance and challenge of comparing stroke care, utilization and outcomes in Medicare Advantage and Fee-for-Service Medicare: a narrative review and vision for the future

    Emily J. Bian; Priyanka Menon; Kathleen A. McManus et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Stroke prevalence is highest in adults ≥65 years, the majority of whom are Medicare beneficiaries. Feefor- Service Medicare (FFS) incentivizes utilization by paying for each service. Medicare Advantage (MA) uses capitated payments to reduce overutilization. It is not clear if stroke patients with…

  14. Journal Article

    Effectiveness and safety of therapies for patients with opioid use disorder: a systematic review and network meta-analysis

    Madhusudan Kabra; Tushar Srivastava; Raju Gautam et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Aim: Opioid use disorder (OUD) leads to significant morbidity and mortality. While opioid agonist therapies like transmucosal buprenorphine and methadone are effective, they face challenges such as poor adherence, diversion risk and suboptimal abstinence rates, prompting the development of…

  15. Journal Article

    Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer

    Neal Shore; Alicia K Morgans; Noman Paracha et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Aim: Recent network meta-analyses (NMAs) in metastatic castration-sensitive prostate cancer have not adequately addressed potential treatment effect modifiers and population imbalances, which introduces bias. Although, individual-patient data (IPD) are seldom available across all trials, recent…

  16. Journal Article

    Acthar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective

    Jas Bindra; Ishveen Chopra; Kyle Hayes et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Aim: Proteinuria poses a significant challenge in focal segmental glomerulosclerosis (FSGS), particularly when resistant to standard treatments. Acthar R Gel, a Food and Drug Administration (FDA)-approved treatment, may be a potential option for proteinuria in nephrotic syndrome (NS) due to FSGS…

  17. Journal Article

    Difference in hospital readmission among patients with atrial fibrillation undergoing ablation using nonintegrated pulsed field catheter with CARTO™ 3 versus EnSite™ electroanatomical mapping system

    Alexandru I Costea; Rahul Khanna; Maximiliano Iglesias et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Aim: Pulsed field ablation (PFA) is a minimally thermal alternative to traditional thermal catheter ablation for atrial fibrillation (AF), with comparable efficacy and minimal risk of collateral tissue injury. Three-dimensional (3D) electroanatomical mapping systems have been adopted with…

  18. Journal Article

    Indirect comparisons of tucatinib in combination with trastuzumab for patients with previously treated HER2–positive metastatic colorectal cancer

    Claire Watkins; Cyndy Simon; Peter Martin et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Aim: In the single-arm MOUNTAINEER trial (NCT03043313) tucatinib in combination with trastuzumab showed an objective response rate (ORR) of 39.3% in patients with previously treated, HER2+unresectable or metastatic colorectal cancer (mCRC). This study compared the efficacy of tucatinib in…

  19. Journal Article

    The impact of socioeconomic crisis on cancer patient outcomes in Lebanon, 2018–2020

    Joel Ladner; Joseph Saba; Anas Nofel et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Aim: The goal of this study was to assess the impact of economic and social crisis on access to cancer care in Lebanon. Materials & methods: A cancer Drug Access Program in Lebanon was launched, covering 80– 90% of treatment costs. The program included three drugs for breast cancer, renal cancer…

  20. Journal Article

    Comparison of deep prostate-specific antigen response in Black patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide

    Benjamin H Lowentritt; Sabree Burbage; Ibrahim Khilfeh et al.

    Journal of Comparative Effectiveness Research, Vol. 15 No. 2 · 2026 · English · DOAJ Scopus

    Aim: There is limited real-world evidence about prostate-specific antigen (PSA) response to androgen receptor pathway inhibitor treatment in Black patientswithmetastatic castration-sensitive prostate cancer (mCSPC). This study compared PSA90 (≥90% reduction from baseline PSA level) between…